News Releases
Jan 23 2018
Avid Bioservices to Present at NobleCon14
Jan 5 2018
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)
Jan 2 2018
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018
Dec 26 2017
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer
Dec 11 2017
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments
Dec 7 2017
Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock
Dec 4 2017
Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 11, 2017
Nov 28 2017
Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement
Nov 13 2017
Peregrine Announces Date of 2017 Annual Meeting of Stockholders
Oct 24 2017
Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices